|
Burden of Illness Models
YHEC undertakes burden of illness studies for any disease area or indication. Such studies are aimed at identifying the overall impact of an illness, including its economic cost to society, and the health consequences of that disease. The models often include a range of potential cost consequences, including the direct medical costs of the disease, as well as the wider societal costs, such as lost productivity and other costs to the patient’s family and carers. Such costs are combined with the underlying epidemiology of that condition in order to provide aggregated outcomes. Likewise, the health consequences are measured using a range of characteristics, including summary outcomes such as quality-adjusted life years, and life years lost.
Some of our recent publications are:
Bagust A, Schoeffski O, Shearer A, Goertz A, Reitberger U, Behrens M. The DiDACT economic model of type 2 diabetes for Germany Diabetes und Stoffwechsel 2003; 12(Suppl 1): 159.  Gordois A, Scuffham PA, Shearer A, Oglesby A. The costs and consequences of peripheral neuropathy in the UK The Diabetic Foot 2003; 6(1): 30-37. Gordois A, Scuffham PA, Shearer A, Oglesby A. The health care costs of diabetic nephropathy in the United Kingdom and the United States Diabetes 2003; 52(Suppl 1): A185-186.
For more details please call Dr Matthew Taylor Project Director (Pharmacoeconomics) on matthew.taylor@york.ac.uk or telephone +44 (0) 1904 323631.
|
